Adimab, LLC

Track

Insider profile

Adimab, LLC's trades of Invivyd, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Invivyd, Inc. (IVVD)
Transaction date
Proposed sale
Price
13.00
Quantity 99,308
Value US$2,398,687
US Invivyd, Inc. (IVVD)
Transaction date
Proposed sale
Price
101.98
Quantity 50,317
Value US$3,319,508
US Invivyd, Inc. (IVVD)
Transaction date
Sale
Price
59.49
Quantity 69,772 +37.5%
Value US$4,661,454
US Invivyd, Inc. (IVVD)
Transaction date
Proposed sale
Price
3.95
Quantity 5,000,000
Value US$19,750,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-23 2025-12-23
US Invivyd, Inc. (IVVD)
PrS Proposed sale
99,308
13.00
US$2,398,687 		99,308 13.00 US$2,398,687
2025-11-17 2025-11-17
US Invivyd, Inc. (IVVD)
PrS Proposed sale
50,317
101.98
US$3,319,508 		50,317 101.98 US$3,319,508
2024-01-22 2024-01-19
US Invivyd, Inc. (IVVD)
S Sale
69,772 +37.5%
59.49
US$4,661,454 		69,772 +37.5% 59.49 US$4,661,454
2024-01-19 2024-01-19
US Invivyd, Inc. (IVVD)
PrS Proposed sale
5,000,000
3.95
US$19,750,000 		5,000,000 3.95 US$19,750,000